CVS Memory Booster Marketing Settlement Gets Early Nod

CVS Pharmacy Inc. and consumers won tentative approval of an uncapped settlement that will give full refunds to some who bought the company’s “Algal-900 DHA” memory aid.

The deal resolves allegations that CVS deceptively touted the supplement as “clinically shown to improve memory” and/or that it provided “clinically proven memory improvement.”

CVS also agreed not to make those labeling statements.

The settlement heads to a Sept. 26 final approval hearing in the U.S. District Court for the Eastern District of New York.

The court certified a nationwide settlement class of all consumers who purchased one or more Algal-900 DHA products ...